Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CXCR3 | P49682 | 8/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30832576 | 1.00 | MAPK1 (0.41) | MAPK1TSHRKDM4EHTTTDP1 | |
| SCHEMBL30832579 | 1.00 | MAPK1 (0.41) | MAPK1TSHRKDM4EHTTTDP1 | |
| SCHEMBL30898822 | 0.70 | — | — | |
| SCHEMBL30832587 | 0.70 | — | — | |
| SCHEMBL30832571 | 0.69 | MAPK1 (0.41) | MAPK1TSHRKDM4EHTTTDP1 | |
| SCHEMBL30832578 | 0.69 | MAPK1 (0.41) | MAPK1TSHRKDM4EHTTTDP1 | |
| SCHEMBL30832577 | 0.69 | MAPK1 (0.41) | MAPK1TSHRKDM4EHTTTDP1 | |
| SCHEMBL11074361 | 0.69 | MAPK1 (0.55) | MAPK1TSHRKDM4EHTTTDP1 | |
| SCHEMBL11375287 | 0.69 | — | — | |
| SCHEMBL11380881 | 0.68 | FAAH (0.31) | TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078080-A1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2026-03-19 | — | — | US | disclosed |
| EP-4581007-A1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2025-07-09 | — | — | EP | disclosed |
| CN-119790032-A | Dimethyl bicycloheptenyl and dimethyl bicycloheptyl derivatives and their use as flavouring agents | 奇华顿股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| WO-2024045134-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024047093-A1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2024-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078080-A1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | GALR1, GALK1, GALR2 | MAPK1 216/4885TSHR 2548/4885KDM4E 3062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.